In silico oncology: A top-down multiscale simulator of cancer dynamics. Studying the effect of symmetric stem cell division on the cellular constitution of a tumour

IFMBE Proceedings

Volumn 25, Issue 4, 2009, Pages 1830-1833

  Stamatakos, G S ^a   Kolokotroni, E ^a   Dionysiou, D ^a   Georgiadi, E ^a   Giatili, S ^a  

^a NATIONAL TECHNICAL UNIVERSITY OF ATHENS   (Greece)

Author keywords

In silico cancer modelling; In silico oncology; Multiscale cancer modelling; Oncosimulator; Top down approach

Indexed keywords

BIOINFORMATICS; BIOMECHANICS; BIOMEDICAL ENGINEERING; BIOPHYSICS; CELL PROLIFERATION; DISEASES; MEDICAL IMAGE PROCESSING; MEDICAL PHYSICS; ONCOLOGY; PATIENT TREATMENT; STEM CELLS; TUMORS;

CANCER SIMULATIONS; CANCER STEM CELLS; CLINICAL PRACTICES; CLINICAL VALIDATIONS; IN-SILICO; ONCOSIMULATOR; TOP DOWN APPROACHES; TREATMENT OPTIMIZATION;

DISCRETE EVENT SIMULATION;

EID: 77950126601     PISSN: 16800737     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1007/978-3-642-03882-2_486     Document Type: Conference Paper

References (17)

1. Duechting, W., Ulmer, W., Lehrig, R., Ginsberg, T., Dedeleit, E. (1992) Computer simulation and modelling of tumour spheroid growth and their relevance for optimization of fractionated radiotherapy. Strahlenther. Onkol. 168: 354-360.
2. Stamatakos, G.S., Dionysiou, D.D., Zacharaki, E.I., Mouravliansky, N.A., Nikita, K., Uzunoglu, N. (2002) In silico radiation oncology: combining novel simulation algorithms with current visualization techniques. Proc. IEEE 90, No 11: 1764-1777
3. Swanson, K.R., Bridge, C., Murray, J.D., Alvord, Jr E.C. (2003) Virtual and real brain tumors: using mathematical modelling to quantify glioma growth and invasion. J Neurol. Sci. 216: 1-10
4. Wise S.M, Lowengrub J.S., Frieboes H.B., Cristini V. (2008) Three-dimensional multispecies nonlinear tumor growth-I Model and numerical method. J.Theor. Biol. 253: 524-543
5. Alarcon, T., Byrne, H.M., Maini, P.K. (2004) A mathematical model of the effects of hypoxia on the cell-cycle of normal and cancer cells. J. Theor. Biol. 229: 395-411
6. Deisboeck TS, Zhang L, Yoon J, Costa J. (2009) In silico cancer modeling: is it ready for prime time? Nat Clin Pract Oncol. 6: 34-42
7. Graf N. and Hoppe A. (2006) What are the expectations of a clinician from in silico oncology? Proc. of the 2nd International Advanced Research Workshop on In Silico Oncology, Kolympari, Chania, Greece, Sept. 25-26. pp. 36-38.
8. Dionysiou, D. D., Stamatakos, G. S., Uzunoglu, N.K., Nikita, K. S., Marioli, A. ( 2004) A four-dimensional simulation model of tumour response to radiotherapy in vivo: parametric validation considering radiosensitivity, genetic profile and fractionation. J. Theor. Biol. 230:1-20
9. Stamatakos, G. S., Antipas, V.P., Uzunoglu, N. K., Dale, R. G., (2006) A four dimensional computer simulation model of the in vivo response to radiotherapy of glioblastoma multiforme: studies on the effect of clonogenic cell density. Brit. J. Radiology 79: 389-400
10. Stamatakos, G. S., P.Antipas, V., Uzunoglu, N. K., (2006) A spatiotemporal, patient individualized simulation model of solid tumor response to chemotherapy in vivo: the paradigm of glioblastoma multiforme treated by temozolomide. IEEE Trans Biomed. Engineering 53, No 8: 1467-1477
11. G.S.Stamatakos, D.D.Dionysiou, N.M.Graf, N.A.Sofra, C.Desmedt, A.Hoppe, N.Uzunoglu, M.Tsiknakis (2007) The Oncosimulator: a multilevel, clinically oriented simulation system of tumor growth and organism response to therapeutic schemes. Towards the clinical evaluation of in silico oncology. Proceedings of the 29th Annual International Conference of the IEEE EMBS Cite Internationale, August 23-26,, Lyon, France. SuB07.1: 6628-6631
12. Kolokotroni E. A., Stamatakos G. S., Dionysiou D. D., Georgiadi E. Ch., Desmedt Ch., Graf N. M. (2008). Translating Multiscale Cancer Models into Clinical Trials: Simulating Breast Cancer Tumor Dynamics within the Framework of the "Trial of Principle" Clinical Trial and the ACGT Project. Proc. 8th IEEE International Conference on Bioinformatics and Bioengineering (BIBE 2008), Athens, Greece, 8-10 Oct. 2008. IEEE Catalog Number: CFP08266, ISBN: 978-1-4244-2845-8, Library of Congress: 2008907441, Paper No. BE-2.1.1, length: 8 pages (in electronic format).
13. Dionysiou D.D, Stamatakos G.S, Gintides D., Uzunoglu N., Kyriaki K (2008) Critical Parameters Determining Standard Radiotherapy Treatment Outcome for Glioblastoma Multiforme: A Computer Simulation. The Open Biomedical Engineering Journal 2: 43-51.
14. M. Sterin, J. S. Cohen, Y. Mardor, E. Berman, and I. Ringel (2001) Levels of Phospholipid Metabolites in Breast Cancer Cells Treated with Antimitotic Drugs: A 31P-Magnetic Resonance Spectroscopy Study. Cancer Res.,61(20): 7536-7543
15. Descamps S., Lebourhis X., Delehedde M., Boilly B., and Hondermarck H. (1998) Nerve Growth Factor Is Mitogenic for Cancerous but Not Normal Human Breast Epithelial Cells. The Jour Biol Chemi 273 (27): 16659-16662
16. Barnes J. A., Dix D. J., Collins B. W., Luft C., and Allen J. W. (2001) Expression of inducible Hsp70 enhances the proliferation of MCF-7 breast cancer cells and protects against the cytotoxic effects of hyperthermia. Cell Stress & Chaperones 6 (4): 316-325
17. Meyer J. S., McDivitt R., Stone K., Prey M., and Bauer W. (1984) Practical breast carcinoma cell kinetics: review and update. Breast Cancer Research and Treatment, 4: 79-88